BRPI0910534A2 - terapia antiviral - Google Patents
terapia antiviralInfo
- Publication number
- BRPI0910534A2 BRPI0910534A2 BRPI0910534A BRPI0910534A BRPI0910534A2 BR PI0910534 A2 BRPI0910534 A2 BR PI0910534A2 BR PI0910534 A BRPI0910534 A BR PI0910534A BR PI0910534 A BRPI0910534 A BR PI0910534A BR PI0910534 A2 BRPI0910534 A2 BR PI0910534A2
- Authority
- BR
- Brazil
- Prior art keywords
- antiviral therapy
- antiviral
- therapy
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08154878 | 2008-04-21 | ||
PCT/EP2009/054641 WO2009130176A1 (en) | 2008-04-21 | 2009-04-20 | Antiviral Therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0910534A2 true BRPI0910534A2 (pt) | 2015-09-29 |
Family
ID=39830378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0910534A BRPI0910534A2 (pt) | 2008-04-21 | 2009-04-20 | terapia antiviral |
Country Status (16)
Country | Link |
---|---|
US (1) | US20110117563A1 (pt) |
EP (1) | EP2271776A1 (pt) |
JP (1) | JP2011519551A (pt) |
KR (1) | KR20110014979A (pt) |
CN (1) | CN102016072A (pt) |
AU (1) | AU2009240021B2 (pt) |
BR (1) | BRPI0910534A2 (pt) |
CA (1) | CA2719078A1 (pt) |
IL (1) | IL208351A0 (pt) |
MA (1) | MA32274B1 (pt) |
MX (1) | MX2010011587A (pt) |
NZ (1) | NZ588144A (pt) |
RU (1) | RU2010146701A (pt) |
SG (1) | SG190570A1 (pt) |
WO (1) | WO2009130176A1 (pt) |
ZA (1) | ZA201006647B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120101340A (ko) * | 2009-09-03 | 2012-09-13 | 메디뮨 엘엘씨 | 1형 인터페론 진단 |
EP2499493A1 (en) * | 2009-11-14 | 2012-09-19 | F. Hoffmann-La Roche AG | Biomarkers for predicting rapid response to hcv treatment |
EP2561363B1 (en) | 2010-04-21 | 2021-07-14 | Memed Diagnostics, Ltd. | Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof |
WO2013117746A1 (en) | 2012-02-09 | 2013-08-15 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
CN103740755A (zh) * | 2013-12-23 | 2014-04-23 | 中国农业大学 | 猪ifit1基因在抗prrs病毒中的应用 |
AU2015302870B2 (en) | 2014-08-14 | 2021-12-23 | Memed Diagnostics Ltd. | Computational analysis of biological data using manifold and a hyperplane |
US20170234873A1 (en) | 2014-10-14 | 2017-08-17 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof |
CN108699583B (zh) | 2016-03-03 | 2022-11-01 | 米密德诊断学有限公司 | 用于区分细菌和病毒感染的rna决定子 |
CN109804245B (zh) | 2016-07-10 | 2022-10-25 | 米密德诊断学有限公司 | 感染的早期诊断 |
WO2018011795A1 (en) | 2016-07-10 | 2018-01-18 | Memed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
EP3519833B1 (en) | 2016-09-29 | 2024-08-14 | MeMed Diagnostics Ltd. | Methods of prognosis and treatment |
WO2018060999A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of risk assessment and disease classification |
US10209260B2 (en) | 2017-07-05 | 2019-02-19 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050123938A1 (en) * | 1999-01-06 | 2005-06-09 | Chondrogene Limited | Method for the detection of osteoarthritis related gene transcripts in blood |
US20080161203A1 (en) * | 2006-12-27 | 2008-07-03 | Su Chun-Lin | Markers identified for liver fibrosis and cirrhosis and the microarray panel thereof |
-
2009
- 2009-04-20 EP EP09734656A patent/EP2271776A1/en not_active Withdrawn
- 2009-04-20 AU AU2009240021A patent/AU2009240021B2/en not_active Ceased
- 2009-04-20 KR KR1020107023467A patent/KR20110014979A/ko not_active Application Discontinuation
- 2009-04-20 JP JP2011505470A patent/JP2011519551A/ja active Pending
- 2009-04-20 NZ NZ588144A patent/NZ588144A/en not_active IP Right Cessation
- 2009-04-20 CN CN2009801140158A patent/CN102016072A/zh active Pending
- 2009-04-20 US US12/988,760 patent/US20110117563A1/en not_active Abandoned
- 2009-04-20 BR BRPI0910534A patent/BRPI0910534A2/pt not_active IP Right Cessation
- 2009-04-20 SG SG2013030457A patent/SG190570A1/en unknown
- 2009-04-20 WO PCT/EP2009/054641 patent/WO2009130176A1/en active Application Filing
- 2009-04-20 CA CA2719078A patent/CA2719078A1/en not_active Abandoned
- 2009-04-20 RU RU2010146701/15A patent/RU2010146701A/ru not_active Application Discontinuation
- 2009-04-20 MX MX2010011587A patent/MX2010011587A/es not_active Application Discontinuation
-
2010
- 2010-09-16 ZA ZA2010/06647A patent/ZA201006647B/en unknown
- 2010-09-21 IL IL208351A patent/IL208351A0/en unknown
- 2010-10-15 MA MA33258A patent/MA32274B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
IL208351A0 (en) | 2010-12-30 |
NZ588144A (en) | 2012-04-27 |
JP2011519551A (ja) | 2011-07-14 |
MX2010011587A (es) | 2011-05-03 |
SG190570A1 (en) | 2013-06-28 |
EP2271776A1 (en) | 2011-01-12 |
US20110117563A1 (en) | 2011-05-19 |
ZA201006647B (en) | 2011-05-25 |
CA2719078A1 (en) | 2009-10-29 |
MA32274B1 (fr) | 2011-05-02 |
CN102016072A (zh) | 2011-04-13 |
AU2009240021A1 (en) | 2009-10-29 |
AU2009240021B2 (en) | 2013-01-10 |
RU2010146701A (ru) | 2012-05-27 |
KR20110014979A (ko) | 2011-02-14 |
WO2009130176A9 (en) | 2010-01-07 |
WO2009130176A1 (en) | 2009-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC2932970I2 (lt) | Antivirusinė terapija | |
SMT201600351B (it) | Composti antivirali | |
DK2280973T3 (da) | Carbanukleosidanaloge til antiviral behandling | |
BRPI0910534A2 (pt) | terapia antiviral | |
BRPI0916931A2 (pt) | agentes terapêuticos | |
IL207826A0 (en) | Antiviral therapeutic agents | |
BRPI0907376A2 (pt) | Fotobiorretador | |
BRPI0906366A2 (pt) | Inalador | |
BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
BRPI0914817A2 (pt) | inalador | |
BRPI0906779A2 (pt) | Inalador | |
LT3150178T (lt) | Stimuliavimo aparatas | |
BRPI0906367A2 (pt) | inalador | |
BRPI0920743A2 (pt) | ribonucleases terapeuticas | |
BRPI0907522A2 (pt) | biarlamidas | |
BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
BRPI0909634A2 (pt) | 2-aminoquinolinas | |
DE112009000183A5 (de) | Sicherheitsvorreiber | |
BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
BRPI0907863A2 (pt) | pirrolopirimidinacarboxamidas | |
BRPI0909637A2 (pt) | 2-aminoquinolinas | |
AT507449A3 (de) | Dämmstoffbefestiger | |
EP2309854A4 (en) | ACCELERATED THERAPY: | |
BRPI0906369A2 (pt) | Inalador | |
BRPI0909764A2 (pt) | compostos terapêuticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |